Suppr超能文献

哮喘控制测试:在既往未接受哮喘专科医生随访的患者中的可靠性、有效性及反应性。

Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

作者信息

Schatz Michael, Sorkness Christine A, Li James T, Marcus Philip, Murray John J, Nathan Robert A, Kosinski Mark, Pendergraft Trudy B, Jhingran Priti

机构信息

Kaiser-Permanente Medical Center, San Diego, CA 92111, USA.

出版信息

J Allergy Clin Immunol. 2006 Mar;117(3):549-56. doi: 10.1016/j.jaci.2006.01.011.

Abstract

BACKGROUND

The development of the Asthma Control Test (ACT), a short, simple, patient-based tool for identifying patients with poorly controlled asthma, was recently described in patients under the routine care of an asthma specialist.

OBJECTIVES

We sought to evaluate the reliability and validity of the ACT in a longitudinal study of asthmatic patients new to the care of an asthma specialist.

METHODS

Patients (n=313) completed the ACT and the Asthma Control Questionnaire (ACQ) at 2 physician visits (4-12 weeks apart). Pulmonary function was measured, and asthma specialists rated asthma control.

RESULTS

Internal consistency reliability of the ACT was 0.85 (baseline) and 0.79 (follow-up). Test-retest reliability was 0.77. Criterion validity was demonstrated by significant correlations between baseline ACT scores and baseline specialists' ratings of asthma control (r=0.52, P<.001) and ACQ scores (r=-0.89, P<.001). Discriminant validity was demonstrated, with significant (P<.001) differences in mean ACT scores across patients differing in asthma control, pulmonary function, and treatment recommendation. Responsiveness of the ACT to changes in asthma control and lung function was demonstrated with significant correlations between changes in ACT scores and changes in specialists' ratings (r=0.44, P<.001), ACQ scores (r=-0.69, P<.001), and percent predicted FEV1 values (r=0.29, P<.001). An ACT score of 19 or less provided optimum balance of sensitivity (71%) and specificity (71%) for detecting uncontrolled asthma.

CONCLUSIONS

The ACT is reliable, valid, and responsive to changes in asthma control over time in patients new to the care of asthma specialists. A cutoff score of 19 or less identifies patients with poorly controlled asthma.

CLINICAL IMPLICATIONS

In a clinical setting the ACT should be a useful tool to help physicians identify patients with uncontrolled asthma and facilitate their ability to follow patients' progress with treatment.

摘要

背景

哮喘控制测试(ACT)是一种简短、简单、基于患者的工具,用于识别哮喘控制不佳的患者,其开发情况最近在哮喘专科医生常规护理的患者中进行了描述。

目的

我们试图在一项针对新接受哮喘专科医生护理的哮喘患者的纵向研究中评估ACT的可靠性和有效性。

方法

患者(n = 313)在两次医生就诊时(间隔4 - 12周)完成ACT和哮喘控制问卷(ACQ)。测量肺功能,哮喘专科医生对哮喘控制情况进行评分。

结果

ACT的内部一致性信度在基线时为0.85,随访时为0.79。重测信度为0.77。通过基线ACT评分与基线时专科医生对哮喘控制的评分(r = 0.52,P <.001)以及ACQ评分(r = -0.89,P <.001)之间的显著相关性证明了效标效度。通过在哮喘控制、肺功能和治疗建议方面存在差异的患者之间,ACT平均得分有显著(P <.001)差异,证明了区分效度。ACT对哮喘控制和肺功能变化的反应性通过ACT得分变化与专科医生评分变化(r = 0.44,P <.001)、ACQ得分变化(r = -0.69,P <.001)以及预测FEV1值百分比变化(r = 0.29,P <.001)之间的显著相关性得以证明。ACT得分为19或更低时,在检测未控制哮喘方面提供了最佳的敏感性(71%)和特异性(71%)平衡。

结论

对于新接受哮喘专科医生护理的患者,ACT可靠、有效,并且能随时间对哮喘控制的变化做出反应。得分为19或更低可识别哮喘控制不佳的患者。

临床意义

在临床环境中,ACT应是一种有用的工具,可帮助医生识别未控制哮喘的患者,并促进他们跟踪患者治疗进展的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验